Bernard J T, Ameriso S, Kempf R A, Rosen P, Mitchell M S, Fisher M
Department of Neurology, University of Southern California School of Medicine, Los Angeles 90033.
Neurology. 1990 Jan;40(1):154-5. doi: 10.1212/wnl.40.1.154.
We report 2 patients with transient, focal, repetitive, stereotyped episodes of neurologic deficits during treatment with interleukin-2. One patient had recurrent monocular blindness, while the 2nd had recurrent homonymous quadrantanopia. We suggest that these attacks are provoked by endothelial cell activation induced by interleukin-2.